Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
SAGE documentation
Evidence to recommendation table
Clear all
Type of publications
SAGE documentation
(31)
Topics
Evidence to recommendation table
(31)
Available to download in languages
English (EN)
(31)
Regions
Countries
Diseases
COVID-19
(2)
Dengue
(3)
Diphtheria
(1)
Hepatitis B
(2)
Human papillomavirus (HPV)
(3)
Influenza
(1)
Malaria
(2)
Measles
(2)
Mpox // Monkeypox
(1)
Pertussis
(1)
Pneumococcal disease
(2)
Rabies
(2)
Rubella
(2)
Tuberculosis
(6)
Typhoid
(1)
Vaccine topics
Target population
Publication date
31 results found
2024
∙
SAGE
Dengue Evidence to Recommendation
2022
∙
SAGE
Annexes to the Vaccines and immunization for monkeypox interim guidance
2022
∙
SAGE
Annexes to the interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
2022
∙
SAGE
Final annexes Vaccines against influenza: WHO position paper – May 2022
2022
∙
SAGE
GRADE and Evidence to Recommendation tables on RTS,S/AS01 malaria vaccine
2021
∙
SAGE
Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
2020
∙
SAGE
Which combined rubella and congenital rubella syndrome (CRS) control and elimination strategies should be recommended?
2018
∙
SAGE
Should countries considering introduction of CYD-TDV to reduce the burden of dengue use a pre-vaccination screening or population seroprevalence based criteria?
2018
∙
SAGE
Should CYD-TDV be recommended, over no vaccination, to immunocompetent individuals (≥9 years of age) in dengueendemic countries to mitigate the dengue burden of disease?
2018
∙
SAGE
BCG efficacy and effectiveness
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register